Autonomix Medical Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-13.63	-15.43	-1.99	-13.33
Depreciation & Amortization	0.18	0.08	-	-
Other Amortization	-	-	-	0.05
Stock-Based Compensation	1.48	0.62	-	13.17
Other Operating Activities	3.13	8	-	-0.48
Change in Accounts Payable	-0.43	0.32	0.08	0.09
Change in Other Net Operating Assets	1.24	-0.24	0.06	0.12
Operating Cash Flow	-8.04	-6.65	-1.85	-0.39
Capital Expenditures	-0.01	-0.02	-	-
Investing Cash Flow	-0.01	-0.02	-	-
Short-Term Debt Issued	-	-	-	0.4
Long-Term Debt Issued	-	2	-	0.14
Total Debt Issued	-	2	-	0.54
Net Debt Issued (Repaid)	-	2	-	0.54
Issuance of Common Stock	20.89	13.71	0.68	2
Other Financing Activities	-2.24	-1.3	-	-0.11
Financing Cash Flow	18.65	14.41	0.68	2.43
Net Cash Flow	10.61	7.74	-1.18	2.04
Free Cash Flow	-8.05	-6.67	-1.85	-0.39
Free Cash Flow Per Share	-7.59	-9.12	-3.08	-3.74
Levered Free Cash Flow	-4.69	-4.27	-1.11	-
Unlevered Free Cash Flow	-4.58	-4.22	-1.11	-
Change in Net Working Capital	-0.5	0.23	-0.14	-

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q